共 37 条
- [35] Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 884 - 895
- [37] Salivary gland-related pathology within a year after 131-Iodine administration for thyroid remnant ablation. Is there any relationship with the method of patient's preparation (rhTSH/LT4 withdrawal) or the administered iodine activity? EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S349 - S349